Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Old Red Blood Cells May Double Mortality in Trauma Patients

By LabMedica International staff writers
Posted on 07 Oct 2009
Severe trauma patients requiring a major blood transfusion are twice as likely to die if they receive red blood cells (RBCs) stored for a month or longer, according to a new study.

Researchers at the Connecticut Children's Medical Center (Hartford, USA) conducted a retrospective cohort study that included 202 patients with traumatic injuries that compared patients transfused with one or more units of RBCs with a maximum storage age of up to 27 days, to those transfused with one or more RBC units with a maximum storage age greater than or equal to 28 days. More...
These study groups were also matched by the amount of units transfused. Primary outcomes were deep vein thrombosis (DVT) and in-hospital mortality.

The researchers found that in the decreased RBC storage age group, DVT occurred in 16.7% of the patients, compared to 34.5% in the increased storage group. Mortality was 13.9% compared 26.7%, respectively. Patients transfused RBCs of increased storage age had an independent association with mortality, and had an increased incidence of death from multi-organ failure (16%), compared to the decreased RBC age group (7%). The study was published in the September 22, 2009, issue of the open access journal Critical Care, a publication of BioMed Central.

"The preferential use of younger RBCs to critically ill patients has the potential to increase waste due to outdating,” said lead author Philip Spinella, M.D. "Since blood is often a scarce resource this is important and methods need to be developed to minimize waste while providing the most efficacious and safe blood product for a given patient.”

Related Links:

Connecticut Children's Medical Center




Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.